In vitro evolution predicts emerging CoV-2 mutations with high affinity for ACE2 and cross-species binding (2021)
Attributed to:
Delivering innovative translational precision medicine research at the University of Leicester
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2021.12.23.473975
Publication URI: http://dx.doi.org/10.1101/2021.12.23.473975
Type: Preprint